News
Oral Corticosteroids Deemed Ineffective for Rhinosinusitis
Systemic corticosteroids are not effective for symptom control in patients with acute rhinosinusitis.
Your search for oral corticosteroids returned 34 results
Drug News
High Risk of Pulmonary Embolism Seen in Severe Asthma
Patients with asthma are at higher risk of pulmonary embolism, particularly if the asthma is severe or they take oral corticosteroids.
News
Oral Corticosteroid Bursts Carry Risk for Severe Adverse Events
Highest rates of adverse events seen within first month after initiating short course of oral steroids.
News
Do Oral Corticosteroids Reduce Symptom Duration in Acute Lower RTI?
The researchers found that the median duration of cough was 5 days in both the prednisolone and placebo groups (adjusted hazard ratio, 1.11; 95% confidence interval, 0.89 to 1.39; P=0.36).
News
Nurse-Initiated Steroids Improve Pediatric Asthma Care
Nurse initiation of oral corticosteroids before physician assessment of pediatric patients with asthma improves quality and efficiency of care provided in the pediatric emergency department.
Drugs in the Pipeline
Phase 3 Study of Masitinib for the Treatment of Asthma
AB Science announced the recruitment of the first patient in its Phase 3 study evaluating masitinib for severe persistent asthma.
News
Early Treatment Key for Managing Nasal Hemangiomas
General consensus supporting early multimodality treatment for infantile hemangiomas of the nose
News
Factors Associated With Successful Biologics Tapering in RA
There were also significant differences between the groups in concomitant oral corticosteroid use (43.1 vs. 34.8% in the stable treatment and DT groups, respectively) and CRP level (1.9±2.5 vs. 1.1±1.3 respectively).
News
RA Drug Linked to Severe Skin Reaction in Patient with Adult-Onset Still Disease
Diffuse, persistent, pruritic maculopapular rash developed 10 days after tocilizumab treatment
Drug News
FDA Panel Says No to OTC Singulair
A panel of expert advisors to the U.S. Food and Drug Administration voted overwhelmingly against moving the allergy drug Singulair from prescription to over-the-counter status.
